ORPHA:99827
Crimean-Congo hemorrhagic fever
Also known as: CCHF · Congo fever · Congo hemorrhagic fever · Crimean hemorrhagic fever
Publications
6,697
Trials
7
Interventional, condition-specific
Researchers
1,477
Distinct authors in sample
Gene link
—
Readiness
4/6
Stages with a signal
Clinical definition (Orphanet)
Crimean-Congo hemorrhagic fever (CCHF) is a tick-borne zoonotic disease caused by CCHF virus and characterized by initial fever, headache, and malaise followed by gastrointestinal symptoms and, in severe cases, bleeding, shock, and multi-organ system failure.
How rare: How common this is has not been clearly measured.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0020501
- MeSH:D006479
- UMLS:C0019099
- NCIT:C34682
Additional Mondo synonyms (3)
Congo-Crimean hemorrhagic fever · Crimean hemorrhagic fever [CHF Congo virus] · Crimean-Congo haemorrhagic fever
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
4/6 stages with a signal
An interventional trial matched this condition name on ClinicalTrials.gov — see trials below.
- Gene identifiedNot found
No GenCC disease–gene assertion in this build
- LiteraturePresent
6,697 matched papers (4,352 in last 10 years) Source
- Phenotype characterisedPresent
82 HPO annotations (e.g. Increased circulating IgM concentration; Diarrhea; Hematuria) Source
- Animal modelNot found
No Alliance genotype “model of” associations via Monarch for these Mondo IDs
- Orphan designationPartial
1 EMA designation (none yet with FDA orphan-indication approval) — e.g. ribavirin Source
- Interventional trialPresent
7 matched on ClinicalTrials.gov (4 recruiting in sample)
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Not yet — the cause hasn't been pinned down in GenCC.
No strong gene–disease assertion joined for this Orphanet entity.
Phenotypes (Monarch / HPO)
82
Associated phenotypes · MONDO:0020501
- Increased circulating IgM concentration
- Diarrhea
- Hematuria
- Hypertension
- Hyperhidrosis
Showing 5 of 82 — open Monarch for the full list.
Animal models (Monarch / Alliance)
None returned for this Mondo ID. Empty here is not proof that no model organism work exists under another name or gene.
Monarch fetch 2026-07-29
Therapies
Designations, candidates, and chemicals
FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.
Orphan designation (FDA · EMA)
1
Designation · no FDA orphan-indication approval yet
- EMA ribavirinTreatment of Crimean-Congo haemorrhagic fever · 21/03/2018 · PositiveEMA designation
Sources: FDA OOPD · EMA orphan designations
Open Targets candidates
No drugs or clinical candidates returned for this Mondo ID on Open Targets.
CTD chemicals (MyDisease.info)
1 associated chemical. Therapeutic evidence is listed first when present — not a treatment recommendation.
- Ribavirin · therapeutic
Literature
Is anyone studying this?
6,697
6,697 papers — among the better-studied rare conditions, though still a fraction of common-disease literature (breast cancer: over 700,000). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.
6,697 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).
4,352 in the last 10 years · low confidence
Phrase hits: 6,695 · MeSH hits: 25
Who's working on it?
1,477
Distinct author names in 200 sampled papers — named people below.
Who's working on it?
People publishing on this condition (sampled Europe PMC records). Affiliation is the most recent found in that sample.
- 01Büyüktuna SA7 papers · 2026
Department of Infectious Disease and Clinical Microbiology, Sivas Cumhuriyet University School of Medicine, Sivas, Türkiye.
Papers in Europe PMC - 02Hewson R6 papers · 2026
Infectious & Tropical Diseases, Depts. Immunology & Infection/Pathogen Microbiology, London School of Hygiene & Tropical Medicine, London, UK.
Papers in Europe PMC - 03Wang M6 papers · 2026
State Key Laboratory of Virology and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan 430071, China. Electronic address: wangml@wh.iov.cn.
Papers in Europe PMC - 04Wang X6 papers · 2026
State Key Laboratory of Virology and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan 430071, China. Electronic address: wangxi@wh.iov.cn.
Papers in Europe PMC - 05Groschup MH5 papers · 2026
Friedrich-Loeffler -Institut, Institute of Novel and Emerging Diseases, Insel Riems, Germany.
Papers in Europe PMC - 06Hensley LE5 papers · 2026
Zoonotic and Emerging Disease Research Unit, National Bio and Agro-Defense Facility, USDA Agricultural Research Service (ARS), Manhattan, Kansas, United States of America.
Papers in Europe PMC - 07Öksüz C5 papers · 2026
Clinic of Infectious Diseases and Clinical Microbiology, Ministry of Health Sivas State Hospital, Sivas, Turkiye.
Papers in Europe PMC - 08Papa A5 papers · 2026
Medical School, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.
Papers in Europe PMC - 09Rimoin AW5 papers · 2026
Department of Epidemiology, Jonathan and Karin Fielding School of Public Health, University of California, Los Angeles, California, United States of America.
Papers in Europe PMC - 10Baysal C4 papers · 2026
Department of Infectious Diseases and Clinical Microbiology, Sivas Cumhuriyet University Faculty of Medicine, Sivas, Turkiye.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
7
interventional trials for this specific condition
7 interventional trials matched this specific condition name; 4 currently recruiting in our sample. 57 trials are registered for hemorrhagic fever, the broader category — shown separately because they may or may not enrol this specific subtype.
Data as of 11 September 2026
7 interventional trials — more than 77.2% of diseases in the trials denominator have none at all (5501 of 7126; this disease is at the 90.9th percentile).
low confidence · 90.9th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
7 interventional trials matched after quoted-phrase search and title/condition post-filter.
- NCT06799013·RECRUITING·Safety and Immunogenicity of a Self-Amplifying RNA Vaccine Against Crimean-Congo Hemorrhagic Fever
Not reviewed·Conditions: Vaccine · Crimean-Congo Hemorrhagic Fever·Matched via name phrase
- NCT06859619·NOT YET RECRUITING·Serological Measurement of Montpellier Professionals' Contacts with Infectious Agents Responsible for Animal-borne Diseases
Not reviewed·Conditions: Leishmaniasis · Leptospirosis · Brucellosis · Q Fever·Matched via name phrase
- NCT06624787·RECRUITING·Development Of A Rapid Diagnostic Test To Identify Crimean-Congo Haemorrhagic Fever At The Point-Of-Care
Not reviewed·Conditions: Crimean-Congo Haemorrhagic Fever·Matched via name phrase
- NCT06860334·NOT YET RECRUITING·UMIT-2 - Adaptive Phase IIb Platform Trial to Determine the Efficacy and Safety of Therapeutics for CCHF
Not reviewed·Conditions: Crimean-Congo Hemorrhagic Fever·Matched via name phrase
Broader category: hemorrhagic fever
57
Interventional trials for the parent category, exclusive of NCT IDs already counted above. Eligibility for this subtype is not guaranteed.
Worth raising with a clinician. How we count trials.
Recruiting under the broader category
- NCT07543458·NOT YET RECRUITING·Therapeutics for Moderate and Severe Dengue
Not reviewed·Conditions: Dengue · Severe Dengue · Mosquito-Borne Diseases · Vector Borne Diseases·Matched via name phrase
Observational and natural-history studies
1 observational study matches this condition. These do not test a treatment and are not counted in the interventional-trial headline, but they are genuine research: natural-history work often defines the endpoints needed for a future rare-disease trial, and families may be able to enroll.
Recruiting or not-yet-recruiting
- NCT06894758·NOT YET RECRUITING·Development of a Rapid Diagnostic Test to Identify Crimean-Congo Hemorrhagic Fever - Research and Development Testing
Not reviewed·Conditions: Infectious Diseases, Emerging·Matched via name phrase
Other registries (secondary)
Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.
raw 16 · after dedupe 16 · already on CT.gov 1 · kept 0 · parent 0 · uncertain 15 · dropped 0 · fetched 2026-07-30
Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri
No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).
Uncertain / not reviewed (15)
- ctis·2023-508556-18-00·Cancelled·A Phase I Study to Evaluate Safety and Immunogenicity of DNA Vaccine N-pVAX1 against Crimean Congo Hemorrhagic Fever (CCHF-NP-1)
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN26330175·Recruiting·Understanding and managing fevers from infections spread by animals
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN72157798·Recruiting·Developing a vaccine against Bundibugyo ebolavirus
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN49320109·Recruiting·A CAR T trial for amyloid light chain amyloidosis (AL Amyloid)
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN74599367·No longer recruiting·Assessment of the effects on immunity of azithromycin in pulmonary tuberculosis patients
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN11688703·No longer recruiting·Examining lymph node cells to assess how age affects immune responses
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN79071535·Recruiting·Severe malaria in African children: A randomised clinical trial with an adaptive design
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN12351734·No longer recruiting·A study of a new vaccine against Crimean-Congo Haemorrhagic Fever (a life-threatening tick-borne viral disease)
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN26168155·No longer recruiting·Study evaluating the safety and activity of cevostamab (BFCR4350A) given by subcutaneous injection in participants with relapsed or refractory multiple myeloma
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN14935155·No longer recruiting·A first-in-human study to assess the safety of an MVA-based vaccine for Crimean-Congo Haemorrhagic Fever (MVA-CCHF) and the vaccine's ability to generate an immune response
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN13539303·No longer recruiting·An international registry of coronavirus exposure in pregnancy
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN17717312·No longer recruiting·CORONATION: Coronavirus (COVID-19) multinational observational registry
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN11594437·No longer recruiting·Primaquine in African Children: PAC study
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN74074706·No longer recruiting·Multi-centre European study of major infectious disease syndromes - Arboviral compatible febrile illness
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN20984426·No longer recruiting·To assess the efficacy and tolerability of three antimalarial treatments in The Democratic Republic of Congo (DRC)
skipped — LLM skipped (--skip-llm)
Where to find support
Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.
Orphanet entry for Crimean-Congo hemorrhagic fever — check Associations / patient organisations on that page.
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
"Crimean-Congo hemorrhagic fever" OR "Congo fever" OR "Congo hemorrhagic fever" OR "Crimean hemorrhagic fever" OR "Congo-Crimean hemorrhagic fever" OR "Crimean hemorrhagic fever [CHF Congo virus]" OR "Crimean-Congo haemorrhagic fever"
MeSH descriptor terms unioned into the query: Hemorrhagic Fever, Crimean
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Crimean-Congo hemorrhagic fever" OR "Congo fever" OR "Congo hemorrhagic fever" OR "Crimean hemorrhagic fever" OR "Congo-Crimean hemorrhagic fever" OR "Crimean hemorrhagic fever [CHF Congo virus]" OR "Crimean-Congo haemorrhagic fever" OR "Hemorrhagic Fever, Crimean"
Interventional trials matched via: phrase (mesh = registered under a MeSH descriptor no name phrase would catch; recall-expansion = gene / selected parent terms used only for trials).
Study-type breakdown: 7 interventional · 1 observational · 0 expanded access. Only interventional studies enter the trial headline.
Parent-category trials query:
"hemorrhagic fever"
Query health: ok — strategies attempted: phrase, mesh; with hits: phrase, mesh
Run this search on ClinicalTrials.gov
Synonyms dropped by stoplist: CCHF
Confidence reasoning
- Preferred label is multi-word and distinctive
- 1 synonym(s) dropped by stoplist (may under-count)
- No label/synonym collisions with other diseases in this corpus
- Publication count (6697) is extremely high with unknown/missing prevalence — treat as possible over-matching, not proven research intensity
Ingested 2026-07-27T06:20:58.505Z
